Skip to Content

Franklin International Equity I LGIEX

Medalist Rating as of | See Franklin Templeton Investment Hub
  • NAV / 1-Day Return 18.17  /  −0.06 %
  • Total Assets 237.6 Mil
  • Adj. Expense Ratio
    0.950%
  • Expense Ratio 0.950%
  • Distribution Fee Level Above Average
  • Share Class Type Institutional
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 1.0 Mil
  • Status Open
  • TTM Yield 2.53%
  • Turnover 34%

USD | NAV as of Apr 16, 2024 | 1-Day Return as of Apr 16, 2024, 12:24 AM GMT+0

Morningstar’s Analysis LGIEX

Will LGIEX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Franklin International Equity I's Average People Pillar and Process Pillar ratings result in a Morningstar Medalist Rating of Neutral.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings LGIEX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 14.9
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk A/S Class B

2.78 5.7 Mil
Healthcare

ASML Holding NV

2.30 4.7 Mil
Technology

Novartis AG Registered Shares

1.77 3.6 Mil
Healthcare

Invesco Shrt-Trm Inv Treasury Instl

1.70 3.5 Mil
Cash and Equivalents

Nestle SA

1.43 2.9 Mil
Consumer Defensive

Roche Holding AG

1.34 2.8 Mil
Healthcare

Shin-Etsu Chemical Co Ltd

1.13 2.3 Mil
Basic Materials

Allianz SE

1.13 2.3 Mil
Financial Services

L'Oreal SA

1.07 2.2 Mil
Consumer Defensive

UniCredit SpA

1.00 2.1 Mil
Financial Services